Pediatric Mastocytosis Is a Clonal Disease Associated with D816V and Other Activating c-KIT Mutations

被引:279
作者
Bodemer, Christine [1 ,2 ,8 ]
Hermine, Olivier [2 ,3 ,4 ]
Palmerini, Fabienne [2 ,5 ,6 ]
Yang, Ying [6 ]
Grandpeix-Guyodo, Catherine [2 ]
Leventhal, Phillip S. [7 ]
Hadj-Rabia, Smail [8 ]
Nasca, Laurent [5 ,6 ]
Georgin-Lavialle, Sophie [2 ,3 ]
Cohen-Akenine, Annick [7 ]
Launay, Jean-Marie [9 ]
Barete, Stephane [2 ,3 ]
Feger, Frederic [3 ]
Arock, Michel [3 ]
Catteau, Benoit [10 ]
Sans, Beatrix [11 ]
Stalder, Jean Francois [12 ]
Skowron, Francois [13 ]
Thomas, Luc [14 ]
Lorette, Gerard [15 ]
Plantin, Patrice [16 ]
Bordigoni, Pierre [17 ]
Lortholary, Olivier [2 ,8 ,18 ]
de Prost, Yves [8 ]
Moussy, Alain [7 ]
Sobol, Hagay [5 ,19 ,20 ]
Dubreuil, Patrice [5 ,6 ]
机构
[1] Univ Paris 05, Serv Dermatol, Hop Necker, F-75743 Paris 15, France
[2] Fac Med Necker Enfants Malad, CEREMAST, Ctr Reference Mastocytoses, Paris, France
[3] Univ Paris 05, Hop Necker, AP HP, CNRS UMR 8147, F-75743 Paris 15, France
[4] Hop Necker Enfants Malad, Serv Hematol Adulte, Paris, France
[5] Univ Mediterranee, Dept Oncol Genet Prevent & Depistage, Inst J Paoli I Calmettes, Marseille, France
[6] Ctr Rech Cancerol Marseille, INSERM U891, Lab Hematopoiese Mol & Fonct, Marseille, France
[7] AFIRMM, Paris, France
[8] Univ Paris 05, Paris, France
[9] Hop Lariboisiere, Serv Biochim & Biol Mol, F-75475 Paris, France
[10] CHU Lille, Hop Claude Huriez, Serv Dermatol, F-59037 Lille, France
[11] Hop Purpan, Serv Dermatol Venerol & Allergol, Toulouse, France
[12] CHU Nantes, Hop Hotel Dieu, Serv Dermatol, F-44035 Nantes 01, France
[13] Ctr Hosp Valence, Serv Dermatol, Valence, France
[14] Hop Hotel Dieu, Serv Dermatol, F-69288 Lyon, France
[15] CHU Trousseau, Serv Dermatol, F-37044 Tours, France
[16] Hop Laennec, Serv Dermatol, F-75340 Paris, France
[17] Hop Brabois, Dept Hematol Oncol, Vandoeuvre Les Nancy, France
[18] Hop Necker Enfants Malad, AP HP, Dept Malad Infect & Trop, Paris, France
[19] INSERM, CIC P 9502, F-13258 Marseille, France
[20] Univ Aix Marseille 2, F-13284 Marseille 07, France
关键词
RECEPTOR TYROSINE KINASE; STEM-CELL FACTOR; MAST-CELL; CUTANEOUS MASTOCYTOSIS; SYSTEMIC MASTOCYTOSIS; TRANSMEMBRANE DOMAIN; GERMLINE MUTATION; STRUCTURAL BASIS; PHOSPHORYLATION; IDENTIFICATION;
D O I
10.1038/jid.2009.281
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Adult mastocytosis is an incurable clonal disease associated with c-KIT mutations, mostly in exon 17 ((DV)-V-816). In contrast, pediatric mastocytosis often spontaneously regresses and is considered a reactive disease. Previous studies on childhood mastocytosis assessed only a few patients and focused primarily on codon 816 mutations, with various results. In this study, we analyzed the entire c-KIT sequence from cutaneous biopsies of 50 children with mastocytosis (ages 0-16 years). A mutation of codon 816 (exon 17) was found in 42% of cases, and mutations outside exon 17 were observed in 44%. Unexpectedly, half of the mutations were located in the fifth Ig loop of c-KIT's extracellular domain, which is encoded by exons 8 and 9. All mutations identified in this study were somatic and caused a constitutive activation of c-KIT. There was no clear phenotype-genotype correlation, no clear relationship between the mutations and familial versus spontaneous disease, and no significant change in the relative expression of the c-KIT GNNK+ and GNNK isoforms. These findings strongly support the idea that, although pediatric mastocytosis can spontaneously regress, it is a clonal disease most commonly associated with activating mutations in c-KIT
引用
收藏
页码:804 / 815
页数:12
相关论文
共 41 条
[1]   A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib [J].
Akin, C ;
Fumo, G ;
Yavuz, AS ;
Lipsky, PE ;
Neckers, L ;
Metcalfe, DD .
BLOOD, 2004, 103 (08) :3222-3225
[2]   Systemic mastocytosis [J].
Akin, C ;
Metcalfe, DD .
ANNUAL REVIEW OF MEDICINE, 2004, 55 :419-432
[3]   Suppressor of cytokine signaling 6 associates with KIT and regulates KIT receptor signaling [J].
Bayle, J ;
Letard, B ;
Frank, R ;
Dubreuil, P ;
De Sepulveda, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) :12249-12259
[4]  
Ben-Amitai D, 2005, ISR MED ASSOC J, V7, P320
[5]   Stem cell factor and hematopoiesis [J].
Broudy, VC .
BLOOD, 1997, 90 (04) :1345-1364
[6]   The fifth immunoglobulin-like domain of the Kit receptor is required for proteolytic cleavage from the cell surface [J].
Broudy, VC ;
Lin, NL ;
Sabath, DF .
CYTOKINE, 2001, 15 (04) :188-195
[7]   Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis:: A possible explanation for divergent clinical behavior [J].
Büttner, C ;
Henz, BM ;
Welker, P ;
Sepp, NT ;
Grabbe, J .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (06) :1227-1231
[8]   Isoforms of c-KIT differ in activation of signalling pathways and transformation of NIH3T3 fibroblasts [J].
Caruana, G ;
Cambareri, AC ;
Ashman, LK .
ONCOGENE, 1999, 18 (40) :5573-5581
[9]   Association of paediatric mastocytosis with a polymorphism resulting in an amino acid substitution (M541L) in the transmembrane domain of c-KIT [J].
Foster, R. ;
Byrnes, E. ;
Meldrum, C. ;
Griffith, R. ;
Ross, G. ;
Upjohn, E. ;
Braue, A. ;
Scott, R. ;
Varigos, G. ;
Ferrao, P. ;
Ashman, L. K. .
BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (05) :1160-1169
[10]   c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia [J].
Gari, M ;
Goodeve, A ;
Wilson, G ;
Winship, P ;
Langabeer, S ;
Linch, D ;
Vandenberghe, E ;
Peake, I ;
Reilly, J .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 (04) :894-900